Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid

Keita Kakuda, Kensuke Ikenaka, Katsuya Araki, Masatomo So, César Aguirre, Yuta Kajiyama, Kuni Konaka, Kentaro Noi, Kousuke Baba, Hiroshi Tsuda, Seiichi Nagano, Takuma Ohmichi, Yoshitaka Nagai, Takahiko Tokuda, Omar Ali El-Agnaf, Hirotsugu Ogi, Yuji Goto, Hideki Mochizuki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

α-Synuclein aggregates, a key hallmark of the pathogenesis of Parkinson’s disease, can be amplified by using their seeding activity, and the evaluation of the seeding activity of cerebrospinal fluid (CSF) is reportedly useful for diagnosis. However, conventional shaking-based assays are time-consuming procedures, and the clinical significance of the diversity of seeding activity among patients remains to be clarified. Previously, we reported a high-throughput ultrasonication-induced amyloid fibrillation assay. Here, we adapted this assay to amplify and detect α-synuclein aggregates from CSF, and investigated the correlation between seeding activity and clinical indicators. We confirmed that this assay could detect α-synuclein aggregates prepared in vitro and also aggregates released from cultured cells. The seeding activity of CSF correlated with the levels of α-synuclein oligomers measured by an enzyme-linked immunosorbent assay. Moreover, the seeding activity of CSF from patients with Parkinson’s disease was higher than that of control patients. Notably, the lag time of patients with Parkinson’s disease was significantly correlated with the MIBG heart-to-mediastinum ratio. These findings showed that our ultrasonication-based assay can rapidly amplify misfolded α-synuclein and can evaluate the seeding activity of CSF.

Original languageEnglish
Article number6001
JournalScientific reports
Volume9
Issue number1
DOIs
Publication statusPublished - 1 Dec 2019

Fingerprint

Synucleins
Cerebrospinal Fluid
Parkinson Disease
3-Iodobenzylguanidine
Mediastinum
Amyloid
Cultured Cells
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • General

Cite this

Kakuda, K., Ikenaka, K., Araki, K., So, M., Aguirre, C., Kajiyama, Y., ... Mochizuki, H. (2019). Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid. Scientific reports, 9(1), [6001]. https://doi.org/10.1038/s41598-019-42399-0

Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid. / Kakuda, Keita; Ikenaka, Kensuke; Araki, Katsuya; So, Masatomo; Aguirre, César; Kajiyama, Yuta; Konaka, Kuni; Noi, Kentaro; Baba, Kousuke; Tsuda, Hiroshi; Nagano, Seiichi; Ohmichi, Takuma; Nagai, Yoshitaka; Tokuda, Takahiko; Ali El-Agnaf, Omar; Ogi, Hirotsugu; Goto, Yuji; Mochizuki, Hideki.

In: Scientific reports, Vol. 9, No. 1, 6001, 01.12.2019.

Research output: Contribution to journalArticle

Kakuda, K, Ikenaka, K, Araki, K, So, M, Aguirre, C, Kajiyama, Y, Konaka, K, Noi, K, Baba, K, Tsuda, H, Nagano, S, Ohmichi, T, Nagai, Y, Tokuda, T, Ali El-Agnaf, O, Ogi, H, Goto, Y & Mochizuki, H 2019, 'Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid', Scientific reports, vol. 9, no. 1, 6001. https://doi.org/10.1038/s41598-019-42399-0
Kakuda, Keita ; Ikenaka, Kensuke ; Araki, Katsuya ; So, Masatomo ; Aguirre, César ; Kajiyama, Yuta ; Konaka, Kuni ; Noi, Kentaro ; Baba, Kousuke ; Tsuda, Hiroshi ; Nagano, Seiichi ; Ohmichi, Takuma ; Nagai, Yoshitaka ; Tokuda, Takahiko ; Ali El-Agnaf, Omar ; Ogi, Hirotsugu ; Goto, Yuji ; Mochizuki, Hideki. / Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{2c598a6b722a44bf8746c7002220786d,
title = "Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid",
abstract = "α-Synuclein aggregates, a key hallmark of the pathogenesis of Parkinson’s disease, can be amplified by using their seeding activity, and the evaluation of the seeding activity of cerebrospinal fluid (CSF) is reportedly useful for diagnosis. However, conventional shaking-based assays are time-consuming procedures, and the clinical significance of the diversity of seeding activity among patients remains to be clarified. Previously, we reported a high-throughput ultrasonication-induced amyloid fibrillation assay. Here, we adapted this assay to amplify and detect α-synuclein aggregates from CSF, and investigated the correlation between seeding activity and clinical indicators. We confirmed that this assay could detect α-synuclein aggregates prepared in vitro and also aggregates released from cultured cells. The seeding activity of CSF correlated with the levels of α-synuclein oligomers measured by an enzyme-linked immunosorbent assay. Moreover, the seeding activity of CSF from patients with Parkinson’s disease was higher than that of control patients. Notably, the lag time of patients with Parkinson’s disease was significantly correlated with the MIBG heart-to-mediastinum ratio. These findings showed that our ultrasonication-based assay can rapidly amplify misfolded α-synuclein and can evaluate the seeding activity of CSF.",
author = "Keita Kakuda and Kensuke Ikenaka and Katsuya Araki and Masatomo So and C{\'e}sar Aguirre and Yuta Kajiyama and Kuni Konaka and Kentaro Noi and Kousuke Baba and Hiroshi Tsuda and Seiichi Nagano and Takuma Ohmichi and Yoshitaka Nagai and Takahiko Tokuda and {Ali El-Agnaf}, Omar and Hirotsugu Ogi and Yuji Goto and Hideki Mochizuki",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-42399-0",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid

AU - Kakuda, Keita

AU - Ikenaka, Kensuke

AU - Araki, Katsuya

AU - So, Masatomo

AU - Aguirre, César

AU - Kajiyama, Yuta

AU - Konaka, Kuni

AU - Noi, Kentaro

AU - Baba, Kousuke

AU - Tsuda, Hiroshi

AU - Nagano, Seiichi

AU - Ohmichi, Takuma

AU - Nagai, Yoshitaka

AU - Tokuda, Takahiko

AU - Ali El-Agnaf, Omar

AU - Ogi, Hirotsugu

AU - Goto, Yuji

AU - Mochizuki, Hideki

PY - 2019/12/1

Y1 - 2019/12/1

N2 - α-Synuclein aggregates, a key hallmark of the pathogenesis of Parkinson’s disease, can be amplified by using their seeding activity, and the evaluation of the seeding activity of cerebrospinal fluid (CSF) is reportedly useful for diagnosis. However, conventional shaking-based assays are time-consuming procedures, and the clinical significance of the diversity of seeding activity among patients remains to be clarified. Previously, we reported a high-throughput ultrasonication-induced amyloid fibrillation assay. Here, we adapted this assay to amplify and detect α-synuclein aggregates from CSF, and investigated the correlation between seeding activity and clinical indicators. We confirmed that this assay could detect α-synuclein aggregates prepared in vitro and also aggregates released from cultured cells. The seeding activity of CSF correlated with the levels of α-synuclein oligomers measured by an enzyme-linked immunosorbent assay. Moreover, the seeding activity of CSF from patients with Parkinson’s disease was higher than that of control patients. Notably, the lag time of patients with Parkinson’s disease was significantly correlated with the MIBG heart-to-mediastinum ratio. These findings showed that our ultrasonication-based assay can rapidly amplify misfolded α-synuclein and can evaluate the seeding activity of CSF.

AB - α-Synuclein aggregates, a key hallmark of the pathogenesis of Parkinson’s disease, can be amplified by using their seeding activity, and the evaluation of the seeding activity of cerebrospinal fluid (CSF) is reportedly useful for diagnosis. However, conventional shaking-based assays are time-consuming procedures, and the clinical significance of the diversity of seeding activity among patients remains to be clarified. Previously, we reported a high-throughput ultrasonication-induced amyloid fibrillation assay. Here, we adapted this assay to amplify and detect α-synuclein aggregates from CSF, and investigated the correlation between seeding activity and clinical indicators. We confirmed that this assay could detect α-synuclein aggregates prepared in vitro and also aggregates released from cultured cells. The seeding activity of CSF correlated with the levels of α-synuclein oligomers measured by an enzyme-linked immunosorbent assay. Moreover, the seeding activity of CSF from patients with Parkinson’s disease was higher than that of control patients. Notably, the lag time of patients with Parkinson’s disease was significantly correlated with the MIBG heart-to-mediastinum ratio. These findings showed that our ultrasonication-based assay can rapidly amplify misfolded α-synuclein and can evaluate the seeding activity of CSF.

UR - http://www.scopus.com/inward/record.url?scp=85064248628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064248628&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-42399-0

DO - 10.1038/s41598-019-42399-0

M3 - Article

C2 - 30979935

AN - SCOPUS:85064248628

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 6001

ER -